相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatectomy with Perioperative Chemotherapy for Multiple Colorectal Liver Metastases is the Available Option for Prolonged Survival
Kiyohiko Omichi et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
Limited Prognostic Value of KRAS in Patients Undergoing Hepatectomy for Colorectal Liver Metastases
Yoshinori Takeda et al.
ANNALS OF SURGICAL ONCOLOGY (2022)
The survival benefit of neoadjuvant chemotherapy for resectable colorectal liver metastases with high tumor burden score
Yoshihiko Yonekawa et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
ModifiedFOLFOXIRIWith or Without Cetuximab as Conversion Therapy in Patients withRAS/BRAFWild-TypeUnresectable Liver Metastases Colorectal Cancer: TheFOCULMMulticenter PhaseIITrial
Huabin Hu et al.
ONCOLOGIST (2021)
Resection of Colorectal Liver Metastasis: Prognostic Impact of Tumor Burden vs KRAS Mutational Status
Diamantis Tsilimigras et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2021)
Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy? A Retrospective Multicentric Study
Alexandre Chebaro et al.
ANNALS OF SURGERY (2021)
Liver venous deprivation compared to portal vein embolization to induce hypertrophy of the future liver remnant before major hepatectomy: A single center experience
Kosuke Kobayashi et al.
SURGERY (2020)
A Multicenter Phase 2 Trial to Evaluate the Efficacy of mFOLFOX6+Cetuximab as Induction Chemotherapy to Achieve R0 Surgical Resection for Advanced Colorectal Liver Metastases (NEXTO Trial)
Yoshihiro Mise et al.
ANNALS OF SURGICAL ONCOLOGY (2020)
Clinical significance of subcentimeter pulmonary nodules in patients undergoing hepatectomy for colorectal liver metastases
Shoji Kawakatsu et al.
JOURNAL OF SURGICAL ONCOLOGY (2020)
Optimal indication criteria for neoadjuvant chemotherapy in patients with resectable colorectal liver metastases
Hirofumi Ichida et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2019)
The Tumor Burden Score: A New Metro-ticket Prognostic Tool For Colorectal Liver Metastases Based on Tumor Size and Number of Tumors
Kazunari Sasaki et al.
ANNALS OF SURGERY (2018)
Surgical treatment options following chemotherapy plus cetuximab or bevacizumab in metastatic colorectal cancer-central evaluation of FIRE-3
D. P. Modest et al.
EUROPEAN JOURNAL OF CANCER (2018)
Long-term outcomes of radiofrequency ablation combined with hepatectomy compared with hepatectomy alone for colorectal liver metastases
K. Imai et al.
BRITISH JOURNAL OF SURGERY (2017)
The ALPPS Risk Score: Avoiding Futile Use of ALPPS
Michael Linecker et al.
ANNALS OF SURGERY (2016)
Parenchymal-Sparing Hepatectomy Does Not Increase Intrahepatic Recurrence in Patients with Advanced Colorectal Liver Metastases
Masaru Matsumura et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
Parenchymal-sparing hepatectomy for deep-placed colorectal liver metastases
Ryota Matsuki et al.
SURGERY (2016)
Failure to Achieve a 2-Stage Hepatectomy for Colorectal Liver Metastases How to Prevent It?
Katsunori Imai et al.
ANNALS OF SURGERY (2015)
Managing synchronous liver metastases from colorectal cancer: A multidisciplinary international consensus
Rene Adam et al.
CANCER TREATMENT REVIEWS (2015)
Early Survival and Safety of ALPPS First Report of the International ALPPS Registry
Erik Schadde et al.
ANNALS OF SURGERY (2014)
Use and Dissemination of the Brisbane 2000 Nomenclature of Liver Anatomy and Resections
Steven M. Strasberg et al.
ANNALS OF SURGERY (2013)
Safety and efficacy of hepatic vein reconstruction for colorectal liver metastases
Akio Saiura et al.
AMERICAN JOURNAL OF SURGERY (2011)
Surgical management and outcomes of colorectal cancer liver metastases
E. J. A. Morris et al.
BRITISH JOURNAL OF SURGERY (2010)
Impact of portal vein embolization on long-term survival of patients with primarily unresectable colorectal liver metastases
D. A. Wicherts et al.
BRITISH JOURNAL OF SURGERY (2010)
The Timing of Chemotherapy and Surgery for the Treatment of Colorectal Liver Metastases
Bernard Nordlinger et al.
CLINICAL COLORECTAL CANCER (2010)
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
Gunnar Folprecht et al.
LANCET ONCOLOGY (2010)
Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?
Rene Adam et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer - A multifactorial model of 929 patients
Myrddin Rees et al.
ANNALS OF SURGERY (2008)
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
C. Barone et al.
BRITISH JOURNAL OF CANCER (2007)
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer:: The Gruppo Oncologico Nord Ovest
Alfredo Falcone et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: A North Central Cancer Treatment Group Phase II study
SR Alberts et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Effect of steatohepatitis associated with irinotecan or oxaliplatin pretreatment on resectability of hepatic colorectal metastases
FG Fernandez et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2005)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors
R Adam et al.
ANNALS OF SURGERY (2000)
分享论文
